Treatment

CryptiVax-1001 clinical trials

1 indexed studies · 1 currently recruiting

RecruitingPHASE1
Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
This study is testing a new experimental vaccine, CryptiVax-1001, for advanced ovarian cancer. It aims to see if the vaccine is safe and if it can help stop the cancer from coming back after standard treatments. This is the first time it’s being used in patients.
For: Ovarian Cancer · HGSOC · HGS Ovarian, Fallopian Tube or Primary Peritoneal Cancer
United Kingdom